← Leaderboards
Mark Cobbold
Massachusetts General Hospital
$816,476
Attributed
$816,476
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $408.2K · FY2019–20$500K$375K$250K$125K$0
'19
'20
Funding mix
By agency
NIH$816,476 · 1
By mechanism
P01$816,476 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ralph Weissleder$110,468,710
- Oksana Berezovska$14,319,485
- Thomas J Gardella$10,202,128
- Peter D Caravan$27,832,958
- M. Amin Arnaout$31,171,564
Others in their field
Other Emerging Leaders on “Antibody-Drug Conjugates”
- Elizabeth Fox · St. Jude Children'S Research Hospital$8,840,232
- Kyoji Tsuchikama · University Of Texas Hlth Sci Ctr Houston$3,574,789
- Kendra S. Carmon · University Of Texas Hlth Sci Ctr Houston$3,557,490
- Lawrence Tumey · State University Of Ny,Binghamton$3,053,816
- Dori A Thomas-Karyat · Synthis Therapeutics, Inc.$3,053,581
- Stylianos Bournazos · Rockefeller University$3,043,276
Research focus
Antibody-Drug ConjugatesAntibody LibrariesAntigen ProcessingAntigensAnti-Pd1 TherapyAntitumor EffectAntiviral AgentsAntiviral ImmunityAzacitidineBaseBindingBiological Response Modifier TherapyBloodCancer CellCancer TypeCd8-Positive T-LymphocytesCdh3 GeneCell LineCell Mediated Immune ResponseCell SurfaceClinicClinical ImplementationClinical TrialsAntibodies